Shire to Buy ViroPharma for Around $4.2 Billion

Shire to Buy ViroPharma for Around $4.2 Billion

In order to establish itself in providing treatments for rare disease, Shire Plc is going to buy ViroPharma Inc. The deal has taken place for around $4.2 billion and Shire will be paying $50 a share and that too in cash.

The recent deal is considered to be the third one for Shire. The purchase will allow Shire to have an access to Cinryze, a medicine meant for the treatment of hereditary angioedema, an inflammatory condition.

The company has said that the deal will help in raising Shire's earnings per share. In fact, as the announcement of the deal was made, Shire was able to witness a rise of 3.5% amounting to 2,894 pence.

"It's a deal that fits with our strategy of increased focus on high-growth speciality markets, particularly rare diseases", said Flemming Ornskov, CEO of Shire.

Ornskov talked about Cinryze and said that it will act a grown engine for the company. Moreover, it is an attractive drug that will prove beneficial for the company.

In addition, it has been revealed that Shire has announced that it has been planning to stop a number of programs that are taking place out of the field of rare disease.


FrenchTribune Specials

1.7% Increase in Monthly Social Security and Supplemental Security Income Benefi

The Social Security Administration has revealed in an announcement that there would be a rise of 1.7% in Monthly Social Security and Supplemental Security Income (SSI) benefits for nearly 64 million Americans in 2015.

More than 8 million SSI beneficiaries in addition to more than 58 million Social Security beneficiaries will begin...

Most Popular

Soft drinks increases aging process at the same rate as cigarettes

Drinking sodas and smoking cigarettes both accelerate...

Brain-eating amoeba in water supply leads to indictment of two employees

Two workers at Saint John the Baptist Parish in New...

Europeans remained lactose intolerant well after adopting cheese-making: study

Ancient Europeans remained intolerant to lactose nearly...

Christiana Figuere surges for unity in climate talks

Christiana Figueres, the head of UN'S climate change...

Poll

Can Greece Come out of Economic Problems: